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Abstract
The prevalence of diabetes in the United States in 2015 was 30.3 million people; which is
the equivalent of 9.4% of the population. It is a major contributor to morbidity and
mortality. Depression is often underdiagnosed in these patients, which contributes to
poor self-management and poor health outcomes. In a large primary-care practice on the
East Coast, there is no guideline for depression screening in the diabetic population.
Focusing on this specific primary care setting, the research question addressed the
underdiagnoses of depression in diabetic patients. The project evaluated the prevalence of
depression among patients diagnosed with diabetes by using the U.S. Preventative
Services Task Force (USPSTF) depression screening tool called the Patient Depression
Questionnaire. The Grove Model for Implementing Evidence-Based Guidelines in
Practice Framework was used in systematically integrating the new practice guideline of
screening all diabetes patients for depression. The framework involves identifying the
practice problem, locating, and collecting the most well-founded evidence, and
evaluating the quality of the evidence-based guideline of screening all diabetes patients
for depression. To answer the project question, 135 diabetic patients in a primary care
outpatient setting completed the Patient Depression Questionnaire. Descriptive statistics
was used to describe the sample and determine the frequency of scores throughout the
sample of patients. Ranges of scores and percentages were computed using frequency
distribution. Of these 135 diabetic patients, 63.7% showed some level of depression
ranging from mild to severe, which was undiagnosed prior to the administration of the
screening tool. As a result of the project, recommendations were made to the site to
implement the use of the depression screening tool as policy.
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Section 1: Nature of the Project
Introduction
Depression is associated with morbidity, poor quality of life and mortality; is recognized
as a major health problem for people with diabetes (Winkley, 2013). According to the Centers
for Disease Control and Prevention [CDC] (2013) “Depression is characterized by depressed or
sad mood, diminished interest in activities that used to be pleasurable, weight gain or loss,
psychomotor agitation or retardation, fatigue, inappropriate guilt, difficulties concentrating, as
well as recurrent thoughts of death” (p. 1). According to the CDC (2013), just one episode of
depression places an individual at a 50% risk for experiencing another episode. In addition to
diabetes increasing the risk for depression, diabetes also can make symptoms of depression
worse (National Institute of Mental Health [NIMH], 2011).
The stress of diabetic self-management, such as daily monitoring of blood sugar,
adherence to diabetes medication regimen, eating health and staying active, can contribute to
depression in diabetic patients. Some of the symptoms of depression, such as weight gain,
overeating and decreased interest in self-care, can worsen the symptoms of diabetes. People with
diabetes and depression have more severe diabetes symptoms than people who have diabetes
alone (NIMH, 2011). Even though diabetic depression can have adverse implications on diabetic
self-management, treatment does not guarantee that the patient will be compliant (National
Institute of Mental Health, 2011).
The purpose of the project was to study the prevalence of depression among patients
diagnosed with diabetes utilizing the USPSTF depression screening tool; the Patient Health
Questionnaire (PHQ-9). Adding this tool to the visits for routine diagnostics and monitoring
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may help identify those patients with depression whether caused or exacerbated by the diabetes.
This data might help explain why some diabetic patients also have self-management challenges.
Better management of diabetes has implications for social change: Better management yield
improved health status and fewer complications.
Background
A growing body of scientific evidence has shown that untreated depression in
combination with diabetes causes significant adverse outcomes (Arokiasamy et al., 2015;
Cummings et al., 2016; Kimbro et al., 2014): increased risk for diabetes-related complications,
such as heart disease, blindness, limb amputations, stroke, and kidney disease (World Federation
for Mental Health [WFMH], 2015). Much ground has been gained in explaining the links
between diabetes and depression. Ajilore et al. (2007) and Black et al. (2003) suggested that (a)
each disease is a risk factor for developing the other, (b) the two disorders may share similar
patho-physiological mechanisms, and (c) depression may indicate particularly severe underlying
diabetic illness (WFMH, 2015). The study conducted by Katon et al. (2009) found that people
with diabetes are at least twice as likely to have depression as those in the general population.
Problem Statement
Depression is often under-diagnosed in patients with diabetes, and thus contributes to
poor self-management and poor health outcomes (CDC, 2014). The prevalence of diabetes in the
United States in 2015 was 30.3 million people; which is the equivalent of 9.4% of the population
(CDC, 2017). Diabetes is a major contributor to morbidity and mortality (CDC, 2014). At a
large East Coast, primary care practice with approximately 2,000 medical and psychiatric
patients-of which 50% receive both medical and psychiatric services; 50% are elderly, 40% are
young to middle aged and 10% are children and adolescents. There are no guidelines for
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mandatory depression screening for all diabetic patients within this primary-care practice. Many
of the antidepressant medications increase the risk for diabetes because of the effect on appetite
and weight gain (Bernard et al., 2013). Because of its mixed population of patients this practice
is ideal for studying the prevalence of depression among diabetic patients.
Purpose Statement
The purpose of this quality improvement study was to introduce a validated depression
screening tool into advanced nursing practice in caring for patients with both newly diagnosed
and on-going diabetes management. It was expected that the use of a routine screening tool
would increase the rate of diagnosis and treatment of depression, ultimately contributing to
improved self-management and thus diabetic control (Bogner et al., 2012). This practice
improvement project evaluated the prevalence of depression among patients diagnosed with
diabetes using PHQ-9, the USPSTF depression screening tool. This nine-question patient
questionnaire is self-administered. After the patient answered the questions, all responses were
verbally review by the clinician and the patient to ensure accurate responses to the questions. As
patients with diabetes and depression were identified they were referred for mental health
services within the practice and monitored. After the baseline assessment is established in this
study, the patient will fill out the questionnaire again at the follow-up visits to compare results on
symptomatic improvement or the need for treatment modification. The practice-focused
question was as follows: “What is the prevalence of depression among adult patients diagnosed
with diabetes?”
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Nature of the Project
EBP is the underpinning of nursing practice. In order for EBP to be successfully
translated into practice guidelines and strengthen healthcare delivery it must be adopted by
individual care providers, microsystem, and system leaders, as well as policy makers (Stevens,
2013). Nurse leaders constitute the facilitators for the process of adoption of EBP. DNPprepared nurse leaders are the valuable link between research and practice that helps substantiate
the use of EBP throughout the entire healthcare delivery system (White, Dudley-Brown, 2012).
Nurses go beyond simply applying evidence in practice and actively evaluating the results.
When evidence that is generated from studies is applied to practice in a realistic way, the
evidence is said to have been translated and healthcare delivery is subsequently strengthened
(White & Dudley-Brown, 2012). Nurses are essential in translating evidence into meaningful
performance improvement (White & Dudley-Brown, 2012).
The quality improvement structure for this project was the Plan-Do-Study-Act (PDSA).
The PDSA cycle describes the growth of knowledge through making changes and then reflecting
on the consequences of those changes (The National Diabetes Education Program, 2015). This
model helps inform three fundamental questions of this project:
1. What are we trying to improve? (the aim)
2. How will we know that a change is an improvement? (measurement)
3. What change can we make that will result in an improvement? (plan)
W. Edwards Deming in 1993 created this model which was based on physics principles.
The PDSA Cycle is a systematic series of steps for gaining valuable knowledge for the continual
improvement of a product or process (The W. Edwards Deming Institute, 2016). Also known as
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the Deming Wheel, or Deming Cycle, the concept and application was first introduced to Dr.
Deming by his mentor, Walter Shewhart of the famous Bell Laboratories in New York (The W.
Edwards Deming Institute, 2016). The PDSA cycle can appear somewhat cumbersome and
complex: however, it is identifying, describing, and providing structure for a natural process
whereby groups and teams initiate change within their systems, whether within healthcare or
elsewhere (Donnelly & Kirk, 2015). Using this explicit framework for managing a change
program ensured (a) that members did not drift from the initial objectives, and (b) that there were
valid, achievable measurements that showed improvement- if improvement were realized
(Donnelly & Kirk, 2015). The framework also provided the evidence to support that an
approach of this nature worked. Formalizing change management in this way makes it possible
to sell your intervention to others (Donnelly & Kirk, 2015).
When applying the PDSA model to diabetes and depression management, the aim is to
decrease depressive symptoms, improve blood glucose management to prevent hyperglycemia,
hypoglycemia, and long-term complications (The National Diabetes Education Program, 2015).
Improvement will be evident if (a) HgbA1c values reach target levels, (b) self-monitored glucose
levels are in pre-prandial and postprandial target ranges, (c) adherence to medication or if disease
improves a decrease in medication, and (d) hyperglycemia or hypoglycemia symptoms and
depressive symptoms are absent.
The evaluation process was based on the PDSA model; thus, the evaluation process took
place during the third stage of the study. The evaluation timeline was as follows:
Plan (Stage 1): Takes place 1-3 weeks before program launch date.
Do (Stage 2): Takes place Week 4 which is the start date of the program.
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Study (Stage 3)- At this stage, which starts at the 6-week period, is the first of the evaluation
processes. During this stage, the following is determined:
•

Did the plan for the program result in an improvement in the detection of depression in
this diabetic population?

•

Was the action worth the investment?

•

Where there any unintended side effects?

Act (Stage 4) – During this phase the team determines if the plan was successful. Any
improvements are then standardized and will begin to be used regularly. The long-term plan,
which is outside the scope of this study, is that the tool will be used subsequently at each
scheduled visit to monitor and compare to baseline results. Success is heavily contingent on
ongoing evaluation. Program stakeholders, as well as participants require regular program
updates to assess how well the program is doing. A well-organized evaluation plan can help
ensure that the patient is benefiting from the health program.
Significance
This project has the potential to enhance evidence-based guidelines, which is the routine
screening of diabetic patients for depression. The problem is the co-occurrence of depression in
diabetes. It has been attributed to a variety of factors, including the psychological and
psychosocial impact of the disease, common genetic susceptibility, common pathophysiological
abnormalities, as well as microvascular brain lesions due to diabetes mellitus (Chew-Graham,
2014). This project has the potential to add to the literature to inform policy makers. Policy
advancement requires a clear, concise statement of the problem and the consensus among
stakeholders that the proposed policy will address the problem (Ridenour & Trautman, 2009).
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Those who are directly and indirectly affected by the policy have influence on this process. The
identified stakeholders are employers, health plans, providers, and advocacy groups.
Employers can translate their understanding of the impact of depression on productivity
into funding for employee education programs. The idea is to increase awareness of depression’s
prevalence, symptoms, impact, and effect on other potentially comorbid conditions such as
cardiovascular disease (CVD), diabetes, and cancer. Health plans can facilitate public
understanding and awareness of depression and its impact through member education campaigns,
similar to those used for CVD and cancer. They can offer incentives to network physician
groups, using pay-for-performance models to improve the quality of care and outcomes for
patients with depression and diabetes. Providers and medical groups can work toward the
development and implementation of more up-to-date assessment and treatment guidelines,
especially at the primary care level, to establish practice protocols that include standard
screening for patients with CVD, diabetes, cancer, and other disorders associated with high rates
of depression. Advocacy groups and other patient-representative organizations can help by (a)
supporting employers, health plans, and practitioners in implementing desired reforms by
providing educational materials and legislative assistance; (b)facilitating community
involvement in promoting awareness of behavioral disorders and treatment options; and (c)
reinforcing the importance of encouraging treatment adherence on the part of patients.
Summary and Transition
Section one identified the problem, purpose, question, and the overview of the evidence
based project, studying the prevalence of depression among diabetic patients in primary-care.
Depression is often underdiagnosed in diabetic patients, which contributes to poor selfmanagement and poor health outcomes. The question this project sought to answer: “Is
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depression underdiagnosed in diabetic patients in a specific primary care setting?” The purpose
of this project was to study the prevalence of depression among patients diagnosed with diabetes
by using the USPSTF depression screening tool PHQ-9. The identified problem is that although
there is a direct link between depression, diabetes, and poorer outcomes for patients with
diabetes, there are no clear depression screening policy recommendations for patients with type 1
and type 2 diabetes mellitus. Section two of this project identified the USPSTF recommendation
for routine use of the PHQ-9 for screening depression is the primary-care setting; the relationship
between diabetes and depression; conceptual model used to guide the project; role of the
Advanced Practice Registered Nurse in screening diabetic patients for depression; and the
relevance of this project to nursing practice.
Section 2: Background and Context
With such a large part of the United States population diagnosed with diabetes the true
prevalence of depression among this population is unknown (CDC, 2014). The purpose of this
quality improvement study was to introduce a validated screening tool for depression into the
advanced nursing practice. Patients with newly diagnosed and on-going diabetes management
would be treated. At this time, there is no estimate of depression among the diabetic patients in
the target primary-care center. The practice-focused question was “What is the prevalence of
depression among adult patients diagnosed with diabetes?” The use of a routine screening tool
may increase the rate of diagnosis and treatment of depression, ultimately contributing to
improved self-management and diabetic control (Unutzer & Mijung, 2012).
To identify prospective, peer-reviewed articles and books, the following databases were
searched for the past 5 years: Cochrane Database, Ovid Nursing, CINAHL, SAGE, MEDLINE,
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and Google Scholar. The following keywords were used: diabetes, diabetes management,
diabetes treatment, depression medication and diabetes, diabetes and depression, depression,
depression and chronic diseases, USPSTF depression screening tool, PHQ-9 and the PDSA
model. Data from the following agencies were valuable; Agency for Healthcare Research and
Quality, Centers for Disease Control and Prevention, Joint Commission on Quality and Safety,
National Institute of Mental Health, The National Diabetes Education Program, U.S.
Preventative Services Task Force, and World Federation for Mental Health.
Measurement of Depression
USPSTF issued recommendations, encouraging primary care physicians to routinely
screen their adult patients for depression in clinical settings that have systems in place to ensure
effective treatment and follow-up (Unutzer & Mijung, 2012). The USPSTF recommendations
are based on results from systematic reviews and meta-analyses conducted on depression
screening. The systematic reviews and meta-analyses includes evidence from an earlier review
of thirty-seven studies (Bower et al. 2006; search period 1966-2004) and a current review of
thirty-two studies (search period 2004-2009, USPSTF, 2015). The PHQ-9 is a brief screening
tool that screens for depression (USPSTF, 2015). Such brief screening tools can be easily
administered by office staff, advanced practice providers and/ or physicians during a primary
care visit. Positive response to these questionnaires should alert the primary care provider to
further evaluate the patient for depression. Not all depressed patients will answer positively to
these questionnaires. To address the possible false negatives, clinicians may wish to ask
additional questions about depressive symptoms for patients who appear depressed, who have
difficulty engaging in care, or whose functional impairment seems inconsistent with objective
medical illness (Unutzer & Mijung, 2012).
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PHQ-9 has demonstrated reliability, convergent/discriminant validity, and responsiveness
to change (Cameron et al., 2008). The coefficient alpha range is from 0.83 to 0.92(Cameron et
al., 2008). The concurrent validity was moderate for the PHQ-9, with a Pearson’s correlation of
.7 (p < .001) (Cameron et al., 2008). A study conducted by Cameron et al. (2008) to assess the
psychometric properties of the PHQ-9 and the Hospital Anxiety and Depression Scale (HADSD) for measuring the severity of depression in primary care patients found, that the psychometric
properties of the PHQ-9 were reliable for internal consistency (p < 0.001) in measuring the
severity of depression among a sample of 1063 primary care patients HADS-D (Cameron et al.,
2008). In another study conducted by Hankerson et al. (2015), the PHQ-9 screening tool was
used to assess the feasibility of screening for depression among African-Americans in a faithbased setting. The sample for the study consisted of 122 participants who were administered the
PHQ-9 depression screening tool. From the sample screened, 19.7% were positive for
depression, with more men positive than women (Hankerson et al., 2015). This study found that
it was feasible to use the PHQ-9 to screen for depression and that the prevalence of depression in
the population was higher among men (Hankerson et al., 2015). Even though this study was not
conducted in a primary care setting, it was included to show the simplicity of administration of
the PHQ-9.
In a study conducted by Landis et al. (2013), the PHQ-9 was used to identify 552 adult
patients with depression in a family medicine residency program utilizing integrated
collaborative care (ICC), which is the combination of medical and behavior health services.
Patients that had been identified with depression from the utilization of the PHQ-9 were
subsequently treated using three models of behavior health care over a five-year period within
this program (Landis et al., 2013). During the five-year period, 42% of the patients who
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screened positive for depression achieved remission, which provides evidence of the validity of
the PHQ-9 to identify patients with depression and the use of behavioral health care services to
treat the depression (Landis et al., 2013). A study conducted by Chin et al. (2016), used the
PHQ-9 to identify 2,929 adult primary care patients with no past history of physician- diagnosed
depression over a 12-month period to estimate the incidence and predictors of a positive screen
for depressive symptoms. It was found in this study population that the cumulative incidence of
PHQ-9 screened patients for depression was higher than those reported in earlier studies (Chin et
al., 2016). The positive predictors where being female, lower socioeconomic status, smoker, and
having two comorbidities (Chin et al., 2016).
The USPSTF found that screening and appropriate treatment relieve symptoms and
reduce the number of people suffering from depression. The economic burden of depression is
substantial for individuals as well as society. Costs to an individual may include suffering,
possible side effects from treatment, fees for mental health and medical visits and medications,
time away from work and lost wages, transportation, and reduced quality of personal
relationships. Costs to society may include loss of life, reduced productivity (because of both
diminished capacity while at work and absenteeism from work), and increased costs of mental
health and medical care. Major depressive disorder (MDD) is a common and significant health
care problem. It is the leading cause of disability among adults in high-income countries and is
associated with increased mortality due to suicide and impaired ability to manage other health
issues. Depression has a major impact on quality of life for the patient and affects family
members, especially children. Depression also imposes a significant economic burden through
direct and indirect costs. In the United States, an estimated $22.8 billion was spent on
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depression treatment in 2009, and lost productivity cost an additional estimated $23 billion in
2011 (USPSTF, 2015).
The National Committee for Quality Assurance (NCQA) adapted three existing provider
and practice level depression care quality measures for potential inclusion in the Healthcare
Effectiveness Data and Information Set (HEDIS) using data from electronic clinical data
systems. HEDIS measures are mandated for NCQA accredited health plans. The HEDIS
Depression Care Measure Set was created to utilize the USPSTF PHQ-9 depression screening
tool in order to improve the ability to measure patient outcomes. The HEDIS Depression Care
Measure Set uses patient information collected through Electronic Clinical Data Systems
(ECDS) such as EHRs, clinical registries and electronic case management records (NCQA,
2016). It monitors the percentage of patients 12 years of age and older that have a diagnosis of
major depression who have been administered the PHQ-9 at least once during a four-month
period (NCQA, 2016). NCQA plans a phased implementation for the depression measures,
beginning with Utilization of the PHQ-9 to Monitor Depression Symptoms for Adolescents and
Adults. It is important to begin with this measure, which encourages routine monitoring of
depression symptoms and will improve the ability to measure patient outcomes. HEDIS is used
by over 90% of health care plans in the United States to measure performance and improve
quality of care and health services (NCQA, 2015).

HEDIS measures are specifically defined

and are used to make comparisons among health plans. Each HEDIS measurement is evolved
each year by the National Committee for Quality Assurance (NCQA) in order to ensure that it
stays current (NCQA, 2015).
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The Relationship between Diabetes and Depression
The relationship between diabetes and depression is complex in nature. As it was stated
previously only recent research has revealed that each disease is a risk factor for developing the
other. In a study conducted by Chew-Graham (2014), 367 primary care patients with type 1 and
2 diabetes where administered a questionnaire to obtain data on their depressive symptoms,
diabetes knowledge, and diabetes self-care. A regression analyses was performed utilizing the
severity of depressive symptoms (low, medium, or high) and its impact on adherence to diabetes
self-care and oral hypoglycemic regimens, HbA1c and functional impairment (Chew-Graham,
2014). Those patients in medium and high severity tertiles were significantly less adherent to
dietary recommendations (Chew-Graham, 2014). Patients in the high-severity tertiles had higher
percentages of days in nonadherence to oral hypoglycemic regimens compared to those in the
low-severity tertiles (15% vs 7 %); a greater probability of having an emergency department,
medical inpatient, mental health, or specialty care cost; and poorer mental and physical
functioning (Chew-Graham, 2014). The study concluded that depression in people with diabetes
may lead to poorer concordance with medical management, to reduced motivation for selfmanagement activity, greater severity of the physical illness, higher mortality, and higher
healthcare costs (Chew-Graham, 2014).
Lin et al. (2010) conducted a longitudinal cohort study of 4,623 primary care patients
with type 2 diabetes from 2000 through 2007 to examine the association of depression with risks
for advanced macrovascular and microvascular complications including blindness, end-stage
renal disease, amputations, and renal failure deaths. The study found that major depression was
associated with significantly higher risks of adverse microvascular outcomes hazard ratio 1.36
[95% CI 1.05–1.75] and adverse macrovascular outcomes 1.24 [1.0–1.54] (Lin et al., 2010). Lin
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et al. (2010) concluded that depression can impair glycemic control as a direct result of its effects
on self-care behaviors such as routine finger sticks to check blood glucose levels, taking
medication as prescribed and adherence to diet and exercise regimens. For a long time, diabetic
patients who failed to keep up with their healthcare visits or comply with treatment plans were
written-off as noncompliant, when in fact they could have possibly been exhibiting signs of
depression.
Secondly, the literature points out that diabetic control requires optimal self-care
management. Depression can significantly reduce motivation which impacts self-management
(Chew-Graham, 2014). Poor outcomes in people with comorbid depression and diabetes may
reflect poor self-management. Patients with depression may have feelings of hopelessness
(which may influence their judgements about the effectiveness of treatment), may be more likely
to be socially isolated and lack support, and may struggle with limited concentration and energy
(Chew-Graham, 2014). There are times when the management of one condition conflicts with
the management of the other. For example, some antidepressant medications such as tricyclics
and selective serotonin reuptake inhibitors (SSRIs) can either cause hyperglycemia or
hypoglycemia in diabetic patients (Chew-Graham, 2014).
Thirdly, the literature indicates identification of depression in diabetic patients is essential
to gaining control over this health issue. In patients with diabetes, under-detection of comorbid
depression is common (Coventry et al., 2011). Coventry et al. (2011) conducted a study to
identify and explore barriers to detecting and managing depression in patients with type 1 and 2
diabetes. Qualitative in-depth interviews with 19 primary care healthcare professionals, seven
service users and three carers where conducted. They were asked about their awareness of and
vulnerability to depression in their patients diagnosed with type 1 and type 2 diabetes;
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presentation, detection, and management of depression; communication in the consultation and
training as well as development to improve services for depression in type 1 and 2 diabetic
patients (Coventry et al., 2011). The study found that barriers to detecting and subsequent
management of depression in patients with type 1 and 2 diabetes exist when practitioners
minimize signs and symptoms of depression in their patients as being common responses to the
losses associated with diabetes; when depression in diabetic patients is normalized by
practitioners which prevents recognition and treatment of depression; and when practitioners are
uncertain about how to label depression in patients with diabetes in ways that will facilitate
understanding and future management (Coventry et al., 2011). The time restraint nature of
primary care consultation adds to the barriers of adequate detection as well.
Fourthly, the literature brings to the forefront the issue of diabetes and depression, but
still has not created mandatory guidelines in the recognition and treatment of diabetes and
depression. Guidelines have been shown to improve when they are created for a single disease
but seldom provide specific instruction for the action in the treatment of people with several
conditions. This reflects the way in which clinical evidence is created (in randomized controlled
trials of a single intervention for a single disease) but does not match everyday practice, where
multimorbidity is common (Chew-Graham, 2014). Combining recommendations for patients
with multimorbidity can result in burdensome or even harmful treatment regimens. There is a
need to develop clinical guidelines that are relevant to a patient with diabetes and depression,
rather than to single conditions.
Conceptual Model
The EBP model that was utilized in systematically integrating the new approaches to
diabetes and depression is the Grove Model for Implementing Evidence-Based Guidelines in
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Practice Framework (Grove & Burns, 2013). This framework involves identifying the practice
problem; locating and collecting the most well-founded evidence; and evaluating the quality of
the evidence-based guideline (Grove & Burns, 2013). Through this framework evidence-based
guidelines with clinical knowledge can be implemented in practice to bring about better patient
outcomes (Grove & Burns, 2013). The Grove Model also encourages consistently monitoring
outcomes and refining evidence-based guidelines as needed based on current evidence (Grove &
Burns, 2013).
The Role for Nursing and Advanced Practice Nursing
Nurses have an essential role in working with people living with diabetes and depression.
They are often the first point of care for these individuals. It is of great importance that nurses
have an awareness of the signs and symptoms of depression in their diabetic patients. Clinical
guidelines to improve health status are driven by a profession’s policies regarding evidencebased practices in the delivery of patient care. Although there is a direct link between depression,
diabetes, and poorer outcomes for patients with diabetes, there are no clear depression screening
policy recommendations for type 1 and type 2 diabetes mellitus patients (LaVance, Fairchild &
Rosado, 2015). Nursing organizations are being called upon by the relevant research to come
together to determine an evidence-based set of questions to aid in the assessment of patients who
struggle with diabetes and perhaps other chronic conditions in which depression has been
reported to be a factor that adversely influences patient health outcomes (LaVance, Fairchild &
Rosado, 2015). These efforts would be based on current evidence and, thus, should provide the
follow-up support needed for type 2 Diabetes Mellitus (T2DM) patients to be better equipped to
improve their self-care management (LaVance, Fairchild & Rosado, 2015).
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The practice environment of interest was primary or ambulatory care. Ninety percent of
patient contacts take place in primary care (Lau et al., 2015). Rapid change in healthcare on a
global scale continues to be the drive to implement more clinically and cost-effective
interventions to improve care delivery. The need to reduce the delay in translating evidencebased interventions into every day clinical practice, known as the second translational gap, is
widely acknowledged (Lau et al., 2015). Almost all changes to practice in primary care involve
interventions with multiple interacting components. They include changes in individual
clinicians’ diagnostic and treatment approaches, in operational systems including information
technology, altered divisions of labor between healthcare professionals and organization of care;
and require change at multiple levels (Lau et al., 2015).
For instance, the routine screening of diabetic patients for depression may appear simple
but on closer inspection, it requires change at multiple levels. At the individual level, the need
for education of the health issue of depression among diabetic patients. Organizational structure
and culture are important to facilitate change in routinely screening diabetic patients for
depression including having adequate resources. It is also widely recognized that the policy
context, professional and organizational context, and political economic circumstances impacting
on the healthcare environment impact on the design and implementation of complex
interventions (Lau et al., 2015).
It is first necessary to identify who the stakeholders and end users are that will be
impacted by the change. AHRQ has defined “stakeholders” as persons or groups that have a
vested interest in a clinical decision and the evidence that supports that decision (AHRQ, 2014).
Stakeholders may be patients, caregivers, clinicians, health plans, researchers, advocacy groups,
professional societies, businesses, policymakers, or others (AHRQ, 2014). Each group has a
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unique and valuable perspective (AHRQ, 2014). In adequately addressing the stakeholders and
end users it is necessary to understand which features of the treatment will make the most
difference; which aspects of the illness are of most concern; and how to present the research in a
manner that will make it easier to understand and act upon (AHRQ, 2014). To affect better
patient outcomes, new knowledge must be transformed into clinically useful forms, effectively
implemented across the entire care team within a systems context, and measured in terms of
meaningful impact on performance and health outcomes (Stevens, 2013).
Relevance to Nursing Practice
Clinical microsystems are the front-line units that provide most health care to most
people (McCluskey & Middleton, 2010). They are the places where patients, families and care
teams meet. Central to every clinical microsystem is the patient (McCluskey & Middleton,
2010). Micro systems are the building blocks that form practices (McCluskey & Middleton,
2010). The quality of care can be no better than the quality produced by the small systems that
come together to provide care. Evaluation of the EBP project is essential to its utilization in
improving patient outcomes. It is necessary to know if the EBP project is meeting its intended
goals as well as looking further into areas that need to be modified in order for the project to be
successful. The evaluation process is data driven.
Based on the possible results of the EBP project evaluation, the new practice
guideline/protocol would be mandatory screening of all diabetic patients in the ambulatory care
setting for depression and the subsequent referral to a mental health services for all that have
been found to show signs and symptoms of depression in this clinical setting. The new standards
of care relevant to the new practice guidelines generated from the EBP project are as follows:
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•

The mandatory use of the (PHQ-9) which is an easy to use, self-administered, nine
question depression screening tool questionnaire (Unutzer & Mijung, 2012).

•

Screening for depression every 3-6 months along with HbA1c.

•

Educating patients on specific and nonspecific signs and symptoms of depression as well
as risk factors for depression.
Summary and Transition
Section two of this project identified the USPSTF recommendation for routine use of the

PHQ-9 for screening depression is the primary-care setting; the relationship between diabetes
and depression; conceptual model used to guide the project; role of the Advanced Practice
Registered Nurse in screening diabetic patients for depression; and the relevance of this project
to nursing practice. USPSTF recommends routine use of PHQ-9 to screen all patients for
depression in primary-care facilities. Based on the literature, diabetes and depression are risk
factors for each other and can worsen symptoms of depression and diabetes. The Grove Model
for Implementing Evidence-Based Guidelines in Practice Framework was used to guide the
project. Research has called on nursing organizations to come together to develop a set of
evidence-based questions to assess patients who struggle with diabetes in which depression has
been reported to be a factor that diminishes patient health outcomes. Section three of this project
identified the process of collecting the data; sources of evidence; and analysis and synthesis of
the data.
Section 3: Collection and Analysis of Evidence
This practice improvement project sought to evaluate the prevalence of depression among
patients diagnosed with diabetes through the utilization of USPSTF depression screening tool,
PHQ-9. This nine-question patient questionnaire was self-ministered (Appendix A). After the
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patient filled out the questions, the clinician verbally verified all responses. After the baseline
assessment was established the patient filled out the questionnaire again at subsequent visits to
compare results. With such a large part of the U.S. population diagnosed with diabetes, it’s true
prevalence of depression among this population is unknown. The purpose of this quality
improvement study was to introduce a validated screening tool for depression into the advanced
nursing practice in caring for patients with both newly diagnosed and on-going diabetes
management. The use of a routine screening tool may increase the rate of diagnosis and
treatment of depression, contributing to improved self-management and diabetic control.
Practice-Focused Question
The practice-focused question was “What is the prevalence of depression among adult
patients diagnosed with diabetes?” Out of the question arose a secondary question: “Is
depression underdiagnosed in diabetic patients in a specific primary care setting?” The target
population was primary care adult patients with a diagnosis of diabetes mellitus type 1 and 2.
The tool USPSTF PHQ-9 was used to screen and monitor for depression in the population. This
screening tool was used to initially establish a baseline in each patient within the target
population. The long-term plan, which is outside the scope of this study, is that the tool will be
used subsequently at every 3-month visit to monitor and compare to baseline results. Patients
diagnosed with depression will be documented and monitored through their electronic health
record.
Sources of Evidence
I, the clinician, who is the doctoral student nurse practitioner employed full time by the
clinic, reviewed the charts of diabetic patients over 21 years of age that were seen in the clinic
during a 6-week period. Patients with a recent or existing diagnosis of diabetes mellitus type 1
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and 2 had the screening tool attached to the chart by the medical assistant (MA) for the patient to
complete in the examination room while waiting to be seen by the clinician. The nine questions
in the PHQ-9 corresponded directly to the nine criteria used to diagnose major depressive
disorder in the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). The nine
questions assess the following symptoms:
Over the last 2 weeks, how often have you been bothered by any of the following problems?
a. Little interest or pleasure in doing things
b. Feeling down, depressed, or hopeless
c. Trouble falling/staying asleep, sleeping too much
d. Feeling tired or having little energy
e. Poor appetite or overeating
f. Feeling bad about yourself or that you are a failure or have let yourself or your family down
g. Trouble concentrating on things, such as reading the newspaper or watching television.
h. Moving or speaking so slowly that other people could have noticed. Or the opposite; being
so fidgety or restless that you have been moving around a lot more than usual.
i. Thoughts that you would be better off dead or of hurting yourself in some way (Cameron et
al., 2008).

Each of the nine areas are rated from 0-3, with three being the most frequent and severe amount
of times that the depressive symptoms are experienced (Cameron et al., 2008). The score is
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added up and can range from 0-27 (Cameron et al., 2008). A score of zero indicates no
depression. A score of 1-4 would signify minimal depression and a score of 5-27 would denote
mild to severe levels of depression.
I reviewed the findings with the patient and noted the score on the EMR and whether
additional diagnosis and treatment was recommended. I reviewed the results of the diabetic
patients and used descriptive statistics to note those whose scores were five or above, denoting
moderate to severe depression. Those patients whose score were five or above were directly
referred to mental health services within the clinic with their consent. Since this was an
additional diagnostic tool used for all diabetic patients, informed consent was not necessary. All
data used for analysis was coded and kept in a locked, secure office. The data was added to the
EMR, which is secured and all applicable HIPAA measures were followed in the practice.
Analysis and Synthesis
The PHQ-9 score was measured using the HEDIS Depression Care Measures Set. The
data generated using this measure will be utilized to inform practice. Descriptive statistics was
used to describe the sample and determine the frequency of scores throughout the sample of
patients. Ranges of scores and percentages were computed. To show clinical significance a
power analysis was conducted and concluded that a sample population of 190 diabetic patients
would render a power of 0.80 and a 5% type I error rate (Power and Sample Size, 2013).
Summary and Transition
Depression impacts the mental and physical health of many people living with diabetes.
It is the second leading cause of disability worldwide (NCQA, 2016). This DNP project will
help generate more evidence to support the initiative to regularly screen for, diagnose, and treat
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depression among diabetic patients as well as measure the quality of care that they receive. The
use of patient reported outcome measures helps to understand depression outcomes so that the
disease can be better treated and monitored. This project will bring awareness to the importance
of identification and treatment of depression in diabetic patients so that they can have less
depressive symptoms and obtain better management of their chronic illness. Section four of this
project identified the findings and recommendation; as well as the strengths and weaknesses of
the project.
Section 4: Findings and Recommendations
Introduction
The goal of this project was to introduce a validated depression screening tool into
advanced nursing practice in caring for patients with both newly diagnosed and ongoing diabetes
management. It was expected that the use of a routine screening tool would increase the rate of
diagnosis and treatment of depression, ultimately contributing to improved self-management and
thus diabetic control (Bogner et al., 2012).
Findings and Implications
According to a power analysis, a sample population of 190 diabetic patients was needed
to show clinical significance in the study. After careful review of all patient charts, only 135
patients met the criteria, which was 21 years or older, with a recent or existing diagnosis of
diabetes mellitus type 1 or 2. The sample was 55 participants short because the clinic had only
135 active adult diabetic patients on its roster. Since the study was conducted at this one
primary-care location, there was no other patient population available to generate the additional
55 participants needed for clinical significance. Each of the 135 diabetic patients was screened
once for depression using the PHQ-9 over a six-week period. Table 1 and Figure 1 show the

24
frequency distribution of all the PHQ-9 depression scores from the sample of the 135 diabetic
patients, categorized by severity.
Table 1
PHQ-9 Scores Frequency Distribution

Depression Severity

Frequency

0-4 (Minimal or none)

48

5-9 (Mild)

30

10-14 (Moderate)

12

15-19 (Moderately Severe)

23

20-27 (Severe)

21

FIGURE 1
Histogram for Depression Severity
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As represented in the frequency distribution Table 1 and histogram, 48 of the 135 patients
screened for depression fell within the minimal or none category with scores ranging from 0-4.
30 of the 135 patients fell within the mild category with scores ranging from 5-9. 12 of the 135
patients fell within the moderate category with scores ranging from 10-14. 23 of the 135 patients
fell within the moderately-severe category with scores ranging from 15-19. 21 patients of the
135 fell within the severe category with scores ranging from 20-27. When considering the PHQ9 criteria for a positive screen for depression, which is a score of five or higher; it becomes
evident that the combined totals of the frequency of scores 5 – 27 shows that more than half of
the diabetic patients screened have mild to severe depression. When we look further into the
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demographic breakdown of this group of diabetic patients that screened positive for mild to
severe depression; as represented in Table 2; it is evident that more females than males had a
positive screen for depression. The mean ages of the diabetic patient’s positive for mild to
severe depression range from 27-53 for males and 41-55 for females, which indicates that more
older females than males had a positive screen for depression. These findings are indicative of
the underdiagnosing of depression among diabetic patients in the primary care setting.
Table 2
Demographics of PHQ-9 Depression Screening Participants

Depression Severity

Male

Mean
Age of
Males

Female

Mean
Age of
Females

0-4 (minimal/none)

25

23

53

55

5-9 (Mild)

12

18

49

47

10-14 (Moderate)

3

9

27

42

15-19 (Mod. Severe)

9

13

46

52

20-27 (Severe)

4

18

43

41

Recommendations
Based on the results of this project, new practice guidelines for this clinic are
recommended:
•

The mandatory use of the PHQ-9 depression screening tool along with HbA1c for all
diabetic patients every 3-6 months.

•

Educating diabetic patients on the specific and nonspecific signs and symptoms of
depression, as well as risk factors for depression.

•

Maintenance of an HbA1c of <7% and greater blood pressure and lipid control.

•

Screening for all adolescent diabetic patients ages 12 – 20 years of age.

•

Mandatory training of all current and new health care providers staffed within the clinic
on signs and symptoms of depression and current treatments.
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Recommendations for future research would include:
•

Further examination of the relationship between diabetes and depression.

•

Testing whether or not improvements in depression among diabetic patients improves
self-care management, adherence to medication management and improved HbA1c
values.

•

Looking at the improvement of depression among diabetics with the utilization of
cognitive behavioral therapy (CBT) alone as opposed to the use of CBT and
antidepressant.
Strengths and Limitations

One of strengths of this project is the robust literature review that identified the need for
further research on the prevalence of depression and diabetes in the primary care setting.
Another strength is that this study aids in providing evidential support to the routine screening of
diabetic patients for depression in the primary care setting through the utilization the PHQ-9
depression screening tool. The findings in this project further demonstrate the reliability and
validity of the PHQ-9 depression screening tool as seen in previous studies within the current
literature (Cameron et al., 2008; Hankerson et al., 2015; Landis et al., 2013; Chin et al., 2016;
USPSTF, 2015).
There were some limitations noted in this study as well. The first limitation was the
sample size. As a result of the patient charts reviewed only 135 patients met the criteria for
inclusion into the study, even though the power analysis concluded 190 patients would be
necessary to show clinical significance. Another limitation is that the study did not take into
consideration the literacy level of the diabetic patients that participated in the study. It was
found during review of patient response to the PHQ-9 that a few of the patients screened did not
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understand some of the words used in the PHQ-9, such as the term, pleasure, and further
explanation and or definitions of some other words as well had to be given by the clinician.
Summary and Transition
The findings and recommendations within section four will help in the development of a
depression screening guideline for all diabetic patients within this primary-care clinic, which will
provide better care for this patient population. The development of this project and its findings
has enhanced the understand of the clinical staff on the relationship of diabetes and depression.
These findings will help to expand the screening of depression to all patient with chronic disease.
Section five identified the dissemination plan for the findings of this project the professional
growth of the clinician.
Section 5: Dissemination Plan
The internal plan to disseminate the findings of the project is to present the findings to the
medical director of this private practice, with recommendations to expand the use of the PHQ-9
depression screening tool to all patients; especially those who have been diagnosed with a
chronic disease. The start date for the implementation of such screenings would be effective
immediately. The external plan of dissemination would be to present these findings to other
health care providers in primary care either in a conference setting or through a social media
outlet such as Facebook, which has pages specifically for primary care providers with a
discussion board. Routine screening for depression among diabetic patients is essential in order
for this health issue to be address. One of the major obstacles to overcoming this issue is the
lack of screenings being conducted by health care providers in the primary care setting. The
reasons for this project and its study findings are primarily to educated and encourages health
care providers to screen their diabetic patients for depression and to then refer those who are
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exhibiting depressive behavior to appropriate mental health specialists. If the plan is followed
correctly it would help many diabetic patients get the necessary mental health services, they need
which would subsequently benefit their medical health. It would be unethical to not address this
issue.
As a Family Nurse Practitioner, I would want the results of my diabetes and depression
program published in the Journal for Nurse Practitioners. This journal is an official, scholarly,
peer-reviewed journal of the American Association of Nurse Practitioners and it offers timely
and original articles addressing clinical practice, clinical management, health policy, research,
education, and other issues affecting NPs and other primary, acute and/or long-term health care
providers. Another venue would be the American Diabetes Association Journal. The American
Diabetes Association Journal continues to be the authoritative source for the latest in diabetes
research.
Analysis of Self
I have identified three significant areas of growth related to my professional contribution and
or leadership and they are as follows:
•

Clinical scholarship and analytical methods for evidence-based practice.

•

Health care policy for advocacy in health care.

•

Clinical prevention and population health for improving the Nation’s health.

According to the American Association of Colleges of Nursing (2006), “scholarship and research
are the hallmarks of doctoral education” (p. 11). Before starting this program, I did not
appreciate research as much. It wasn’t until starting this program that I came to understand that
scholarship and research is the foundation of nursing practice. It is what separates nursing from
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other professions. As a DNP we are responsible for the translation of research into practice and
the dissemination and integration of new knowledge (AACN, 2006). According to the AACN
(2006), “health care policy creates a framework that can facilitate or impede the delivery of
health care services or the ability of the provider to engage in practice to address health care
needs” (p. 13). As a result of the training received through this DNP program I feel more
confident in the role of policy maker, and I am looking forward to helping create policy that will
benefit the underserved and often overlooked population in this country. Clinical prevention is
defined as health promotion and risk reduction/illness prevention for individuals and families
(AACN, 2006). This program has help increase my knowledge and ability to analyze
epidemiological, environmental and scientific data related to population health. Understanding
how to implement prevention and population health activities is necessary in order to impact the
goal of improving individual’s health status globally.
Summary
Diabetes is an epidemic throughout the world. There must be global efforts to ultimately
create standardized modules of treatment that will address both diabetes and the mental health
issues that accompany this disease. More primary care organizations will need to incorporate
leadership, creativity and top professionals in mental health and diabetes care to help insure that
this goal is reached. Individuals with diabetes and depression will become empowered through
gaining knowledge and expertise in the management of their condition.
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Appendix A: Patient Health Questionnaire (PHQ-9)

Patient Name: _________________________________________

Date: ___________________

Not at all

Several days

More than
half the days

Nearly every
day

Not difficult
at all

Somewhat
difficult

Very
difficult

Extremely
difficult

1. Over the last 2 weeks, how often have you been bothered by
any of the following problems?

j. Little interest or pleasure in doing things
k. Feeling down, depressed, or hopeless
l. Trouble falling/staying asleep, sleeping too much
m. Feeling tired or having little energy
n. Poor appetite or overeating
o. Feeling bad about yourself or that you are a failure or have
let yourself or your family down

p. Trouble concentrating on things, such as reading the
newspaper or watching television.

q. Moving or speaking so slowly that other people could have
noticed. Or the opposite; being so fidgety or restless that
you have been moving around a lot more than usual.

r. Thoughts that you would be better off dead or of hurting
yourself in some way.
2. If you checked off any problem on this questionnaire so far,
how difficult have these problems made it for you to do
your work, take care of things at home, or get along with
other people?

36
Scoring:
Count the number (#) of boxes checked in a column. Multiply that number by the value indicated below, then add
the subtotal to produce a total score. The possible range is 0-27. Use the table below to interpret the PHQ-9
score.
Not at all
Several days
More than half the days
Nearly every day

(#) _______ x 0 = _______
(#) _______ x 1 = _______
(#) _______ x 2 = _______
(#) _______ x 3 = _______

Total score:

_______

Interpreting PHQ-9 Scores

Actions Based on PH9 Score
Score

Minimal depression

0-4

Mild depression

5-9

Moderate depression

10-14

Moderately severe depression

15-19

Severe depression

20-27

<4

> 5 - 14

> 15

Action
The score suggests the patient may not need depression
treatment
Physician uses clinical judgment about treatment, based
on patient's duration of symptoms and functional
impairment
Warrants treatment for depression, using antidepressant,
psychotherapy and/or a combination of treatment.

